Pages that link to "Q36735442"
Jump to navigation
Jump to search
The following pages link to The effects of antidepressants on the hypothalamic-pituitary-adrenal axis (Q36735442):
Displaying 25 items.
- Omega-3 fatty acids and depression: scientific evidence and biological mechanisms (Q21284717) (← links)
- Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression (Q30467322) (← links)
- Circadian phase and sex effects on depressive/anxiety-like behaviors and HPA axis responses to acute stress (Q30476550) (← links)
- Which clinical and experimental data link temporal lobe epilepsy with depression? (Q31130656) (← links)
- Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms. (Q34315494) (← links)
- Antidepressant-like effects of the aqueous macerate of the bulb of Gladiolus dalenii Van Geel (Iridaceae) in a rat model of epilepsy-associated depression (Q35020588) (← links)
- Total flavonoids extracted from xiaobuxin-tang on the hyperactivity of hypothalamic-pituitary-adrenal axis in chronically stressed rats (Q35105475) (← links)
- Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis (Q35271933) (← links)
- A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. (Q35592045) (← links)
- Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression (Q36442038) (← links)
- Salt craving: the psychobiology of pathogenic sodium intake (Q36800251) (← links)
- Lithium: a versatile tool for understanding renal physiology. (Q36836247) (← links)
- Endocannabinoid system and synaptic plasticity: implications for emotional responses (Q36887168) (← links)
- Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids (Q37631141) (← links)
- Stress-related depression: neuroendocrine, genetic, and therapeutical aspects (Q38016982) (← links)
- Chronobiology of mood disorders (Q38126091) (← links)
- Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background (Q38504481) (← links)
- Desipramine treatment has minimal effects on the brain accumulation of glucocorticoids in P-gp-deficient and wild-type mice (Q38560579) (← links)
- Botanicals for mood disorders with a focus on epilepsy (Q38593584) (← links)
- Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder. (Q39033812) (← links)
- Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review (Q39427752) (← links)
- Biological outcome measurements for behavioral interventions in multiple sclerosis (Q42789516) (← links)
- Depressive-like parameters in sepsis survivor rats (Q43286573) (← links)
- Hippocampus, glucocorticoids and neurocognitive functions in patients with first-episode major depressive disorders. (Q48458465) (← links)
- Vagus nerve stimulation for depression: efficacy and safety in a European study (Q57435819) (← links)